Incidents of infant bleeding are on the rise, as a growing number of parents choose to decline the vitamin K injection for their newborns. A recent study examining the medical records of 11 million infants has revealed a decrease in the administration of vitamin K shots, which has been linked to a significant increase in vitamin K deficiency (VKD) and related bleeding disorders.
:max_bytes(150000):strip_icc():format(jpeg)/young-dad-crying-baby-100925-2-e4f388321b624ad7a6fa9fedbb2db1ed.jpg)
Conducted by researchers from Virginia Commonwealth University, the study collected data from 2017 to 2025. The findings, published in JAMA Pediatrics, highlight a concerning trend: the percentage of infants receiving the vital vitamin K injection fell from 97.7% to 95% during this time frame. Concurrently, cases of vitamin K deficiency rose by 216%, while vitamin K deficiency bleeding surged by an alarming 347%.
Dr. Elizabeth Wolf, the lead researcher and a paediatrician at the Children’s Hospital of Richmond at VCU, noted the significant consequences of this shift. In an official statement, she remarked, “We knew from prior studies that vitamin K refusal had been increasing in the U.S., and we wanted to learn if there were any real-life consequences of this trend. We found that the answer is undeniably yes, with the rates of VKD and VKDB multiplying over the course of our study.”
Newborns, who typically have low levels of vitamin K due to limited placental transfer, inadequate levels in breast milk, and an immature gut that lacks the bacteria necessary for its production, are at risk of serious health complications without the vitamin K shot. The Centers for Disease Control and Prevention (CDC) has advocated for this injection since 1961, stressing its importance in preventing potentially life-threatening bleeding.
Dr. Wolf further cautioned against the growing mistrust of medical professionals, drawing parallels to recent measles outbreaks which have also resulted from vaccine hesitancy. “We are seeing the real-world implications of growing mistrust of doctors and public health professionals. We need clear messaging from all levels of public health about the benefits of vitamin K administration for newborns,” she said.
The consequences of vitamin K deficiency are grave. Affected infants may exhibit symptoms such as bruising and bleeding around the umbilicus, or belly button, within the first week after birth. Should they go without treatment beyond this period, the risks of intracranial haemorrhage rise dramatically, with estimates indicating a 30% to 60% chance of severe bleeding in the brain, which can lead to seizures, permanent neurological damage, or even death.
The study also underscored the severity of these conditions: approximately 7% of babies with vitamin K deficiency and 2% of those with vitamin K deficiency bleeding experienced intracranial or intracerebral hemorrhages. This stark statistic emphasises the potential dangers of declining this crucial preventative measure.
Experts are calling for urgent action to understand the underlying reasons for parental reluctance regarding the vitamin K shot. Dr. Wolf acknowledged the necessity of ongoing research to track these trends, warning that the rates of vitamin K deficiency and associated bleeding could continue to escalate if refusal rates persist.
As this issue garners attention, parents and healthcare professionals alike are urged to engage in open dialogues about the importance of vitamin K injections. Educational efforts must be intensified to ensure that families are informed of the risks associated with vitamin K deficiency and the benefits of timely vaccination.
In conclusion, the declining uptake of vitamin K shots among newborns represents a worrying trend that poses significant health risks. It underscores the need for comprehensive public health messaging and a concerted effort to restore trust in established medical practices. Only through collaborative efforts can we hope to reverse the trend and safeguard the health of future generations.
About the Author
